+22,034.1%
CPRT vs GSK
+899.7%
+21,134.4%
-72.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.4% | -1.9% | +2.3% | +0.9% |
| 7D | +2.2% | -1.8% | +4.0% | +2.7% |
| 30D | +16.6% | -2.2% | +18.8% | +17.3% |
| 3M | +9.6% | -1.8% | +11.4% | +10.0% |
| 6M | -11.1% | -10.6% | -0.5% | -8.6% |
| YTD | -13.9% | +4.4% | -18.3% | -15.3% |
| 1Y | -32.5% | +30.4% | -62.9% | -37.8% |
| 3Y | -25.0% | +60.1% | -85.1% | -35.8% |
| 5Y | -7.4% | +46.8% | -54.2% | -19.6% |
| 10Y | +422.0% | +79.2% | +342.8% | +324.3% |
| All | +22,034.1% | +899.7% | +21,134.4% | +13,301.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling